SQZ BIOTECHNOLOGIES CO - COM (SQZB)

CUSIP: 78472W104

Q1 2023 13F Holders as of 31 Mar 2023

Type / Class
Equity / COM
Total 13F shares
11,357,886
Share change
-1,297,543
Total reported value
$6,362,590
Put/Call ratio
3.3%
Price per share
$0.56
Number of holders
32
Value change
-$995,815
Number of buys
8
Number of sells
15

Quarterly Holders Quick Answers

What is CUSIP 78472W104?
CUSIP 78472W104 identifies SQZB - SQZ BIOTECHNOLOGIES CO - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of SQZ BIOTECHNOLOGIES CO - COM (SQZB) as of Q1 2023

As of 31 Mar 2023, SQZ BIOTECHNOLOGIES CO - COM (SQZB) was held by 32 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 11,357,886 shares. The largest 10 holders included Temasek Holdings (Private) Ltd, AMERICAN INTERNATIONAL GROUP, INC., Artal Group S.A., MAVERICK CAPITAL LTD, VANGUARD GROUP INC, STIFEL FINANCIAL CORP, Laurion Capital Management LP, MORGAN STANLEY, GEODE CAPITAL MANAGEMENT, LLC, and BlackRock Inc.. This page lists 32 institutional shareholders reporting positions in this security for the Q1 2023 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.